• Species Reactivity

  Human

• Specificity

  Detects human PLA2G16 in direct ELISAs and Western blots.

• Source

  Polyclonal Sheep IgG

• Purification

  Antigen Affinity-purified

• Immunogen

  E. coli-derived recombinant human PLA2G16    
  Asp12-Asp132    
  Accession # P53816

• Formulation

  Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.

• Label

  Unconjugated

Applications

• 
  

  Recommended    
  Concentration

  Sample

• Western Blot

  1 µg/mL

  See below

• 
  

Please Note: Optimal dilutions should be determined by each laboratory for each application.  are available in the Technical Information section on our website.

Data Examples

Preparation and Storage

• Reconstitution

  Reconstitute at 0.2 mg/mL in sterile PBS.

• Shipping

  The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C

• Stability & Storage

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles.    

• 12 months from date of receipt, -20 to -70 °C as supplied.

• 1 month, 2 to 8 °C under sterile conditions after reconstitution.

• 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: PLA2G16

Secretory phopholipase A2 (PLA2) enzymes cleave an acyl ester bond in the sn-2 position of glycerophospholipids. These extracellular proteins have a high disulfide bond content, low molecular mass (14 kDa), and require mM levels of Ca2+ for catalysis. They play a crucial role in the generation of arachidonates and eicosanoids, and have a number of biological actions including immunological responses, inflammation, cellular proliferation, vasoconstriction, and bronchioconstriction.

• Long Name:

  Phospholipase A2, Group XVI

• Entrez Gene IDs:

  11145 (Human); 225845 (Mouse); 24913 (Rat)

• Alternate Names:

  Adipose-specific phospholipase A2; AdPLA; AdPLAHRASLS3; EC 3.1.1.4; group XVI phospholipase A2; HRAS-like suppressor 3Ca-independent phospholipase A1/2; HRASLS3; HREV107; H-REV107-1; HREV107-3adipose-specific PLA2; HREV107H-rev 107 protein homolog; MGC118754; phospholipase A2, group XVI; PLA2G16; Renal carcinoma antigen NY-REN-65